Get the app
Novo Nordisk

Novo Nordisk

on
CosmicTaco
CosmicTacoGrapevine12mo

Amgen's Weight-Loss Drug Falls Short, Stock Plummets

  • Amgen's MariTide Phase-2 data showed 20% weight loss at 52 weeks, but stock dropped 13.31% pre-market.
  • Rival stocks Eli Lilly and Novo Nordisk rose on Biden's proposal for expanded Medicare, Medicaid coverage for obesity drugs.
  • Ret...
Post image
CosmicTaco
CosmicTacoGrapevine13mo

The Controversial Rise of Weight Loss Drugs

  • Weight loss drugs like OIC, Zep bound, and Monaro are becoming increasingly popular, despite high costs.
  • These drugs, also known as glucagon-like peptide one drugs, mimic a natural hormone that affects brain signals on appetite and h...
Post image